Eyegene Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eyegene Inc with three other
companies in this sector in KOREA (SOUTH) :
Anterogen Co Ltd
sales of 4.15 billion Korean Won [US$3.67 million]
of which 78%
Cube&Company Co Ltd
(7.38 billion Korean Won [US$6.54 million]
of which 98%
was Synthesis), and
(4.37 billion Korean Won [US$3.87 million]
of which 67%
was Medical Segment).
Eyegene Inc reported sales of 4.25 billion Korean Won (US$3.76 million)
December of 2019.
increase of 108.6%
versus 2018, when the company's sales were 2.04 billion Korean Won .
This was the fourth straight year of sales growth at Eyegene Inc.